Om

Revolution Medicines Inc. is a clinical-stage precision oncology company focused on developing targeted therapies for cancers driven by RAS pathway alterations. Its current pipeline centers on small-molecule programs designed to inhibit mutant and active-state RAS proteins, along with companion approaches that address cooperating signaling nodes involved in tumor growth and survival. The company’s lead candidates include RAS(ON) inhibitors and related oncology programs aimed at treating difficult-to-address solid tumors, with emphasis on pancreatic, lung, and other RAS-dependent cancers. Revolution Medicines works at the intersection of cancer biology and drug discovery, advancing medicines intended for use as standalone treatments and in combination regimens. Headquartered in Redwood City, California, and founded in 2014, Revolution Medicines plays a notable role in the biotechnology market as a specialist developer of precision cancer therapeutics.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I REVOLUTION MEDICINES MED ENDAVU: Køb Revolution Medicines ($RVMD) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Revolution Medicines, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.